Valuation: Renalytix Plc

Market Cap 13.34M 11.72M 10.94M 10.04M 18.79M 1.28B 19.25M 130M 50.73M 632M 50.07M 48.98M 2.19B P/E 2024
-0.45x
P/E 2025 -1.34x
Enterprise Value 17.94M 15.76M 14.71M 13.5M 25.27M 1.72B 25.9M 174M 68.22M 850M 67.34M 65.88M 2.94B EV / Sales 2024
11,059,330x
EV / Sales 2025 12,499,418x
Free-Float
73.31%
Yield 2024 *
-
Yield 2025 -
1 week-1.85%
Current month+15.22%
1 month+39.47%
3 months+47.22%
6 months-55.08%
Current year-55.08%
1 week 2.5
Extreme 2.5
2.8
1 month 1.92
Extreme 1.925
3
Current year 1.6
Extreme 1.6
6.5
1 year 1.6
Extreme 1.6
15.5
3 years 1.6
Extreme 1.6
125
5 years 1.6
Extreme 1.6
1,180
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 15/03/2018
Director of Finance/CFO 68 28/05/2024
President 65 30/04/2024
Director TitleAgeSince
Chairman 62 05/11/2024
Director/Board Member 58 15/03/2018
Chairman 74 -
Date Insider Type Main position Quantity % Market Cap.
13/02/26 Buy

Founder

250 0.0001%
13/02/26 Buy

Chief Financial Officer

500 0.0001%
13/02/26 Buy

Founder

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.85%-64.67%-97.70% 15.41M
+1.44%+1.94%+15.78%-39.89% 15.69B
+0.63%+10.05%+0.58%+99.42% 1.74B
+0.54%+1.02%-33.77%-80.71% 1.14B
+0.88%-2.40%-38.94%+15.08% 976M
+2.34%+2.73%-44.06%-53.05% 633M
+1.73%+1.89%-46.79%-56.39% 517M
-0.67%+3.75%+41.61%-52.51% 470M
+2.26%+3.59%-55.27%-60.60% 376M
+5.68%+7.31%-14.17%-30.48% 355M
Average +1.61%+0.37%-23.97%-35.68% 2.19B
Weighted average by Cap. +1.30%+1.73%+5.15%-29.75%

Financials

2024 2025
Net sales 2.29 2.01 1.88 1.72 3.23 219.25 3.3 22.26 8.71 108.49 8.59 8.41 375.06 3 2.64 2.46 2.26 4.23 287.35 4.33 29.18 11.41 142.19 11.26 11.02 491.56
Net income -33.46M -29.4M -27.44M -25.18M -47.14M -3.2B -48.3M -325M -127M -1.59B -126M -123M -5.48B -20.4M -17.93M -16.73M -15.36M -28.74M -1.95B -29.45M -198M -77.59M -967M -76.59M -74.93M -3.34B
Net Debt 3.86M 3.39M 3.16M 2.9M 5.43M 369M 5.57M 37.49M 14.66M 183M 14.47M 14.16M 632M 4.6M 4.04M 3.77M 3.46M 6.48M 441M 6.64M 44.74M 17.5M 218M 17.27M 16.9M 754M
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
29/07/26 GBX 2.650 0.00% 92,762
28/07/26 GBX 2.650 0.00% 43,274
27/07/26 GBX 2.650 0.00% 32,742
24/07/26 GBX 2.650 0.00% 162,604
23/07/26 GBX 2.650 -1.85% 178,155

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENX Stock